What is Ab E Discovery?
Ab E Discovery, operating under the umbrella of Optum Immunity, is dedicated to advancing poultry health through cutting-edge, patented egg yolk technology. Their flagship product, Cosabody, is engineered to bolster animal immune systems, thereby enhancing production outcomes. The company's core mission revolves around optimizing gastrointestinal tract immunity, empowering animals to better combat parasites and pathogens. Introduced via animal feed, Cosabody aims to reduce mortality rates and elevate egg production, offering poultry industry clients a pathway to improved animal welfare and greater financial returns.
How much funding has Ab E Discovery raised?
Ab E Discovery has raised a total of $323K across 2 funding rounds:
Debt
$150K
Debt
$173K
Debt (2020): $150K with participation from PPP
Debt (2021): $173K led by PPP
What's next for Ab E Discovery?
With substantial backing and a clear focus on late-stage development, Ab E Discovery is poised for significant expansion. The recent strategic investment will likely fuel further research and development, scale manufacturing capabilities, and broaden market penetration within the global poultry sector. This capital infusion is expected to accelerate the adoption of Cosabody, reinforcing Ab E Discovery's commitment to delivering innovative health solutions and driving value for its stakeholders.
See full Ab E Discovery company page
